サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1683383

人工呼吸器の世界市場：2025年～2033年

Global Ventilators Market - 2025-2033

出版日
ページ情報
英文 220 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
人工呼吸器の世界市場：2025年～2033年
出版日: 2025年03月20日
発行: DataM Intelligence
ページ情報: 英文 220 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の人工呼吸器の市場規模は、2024年に60億6,000万米ドルに達し、2033年には183億5,000万米ドルに達すると予測され、予測期間の2025年～2033年のCAGRは11.7%になる見込みです。

世界の人工呼吸器市場は呼吸ケアに不可欠であり、COPD、肺炎、ARDSのような状態の患者に救命支援を提供しています。移動性、タイプ、インターフェース、エンドユーザーに基づいてセグメント化され、集中治療用とポータブル人工呼吸器が主要カテゴリーです。Philips Healthcare、Medtronic、GE Healthcareなどの主要企業が市場を独占する一方、SCHILLER HealthcareやVentis Medical Inc.などの新興企業が革新的なソリューションを導入しています。技術の進歩、呼吸器疾患の増加、非侵襲的換気に対する需要の高まりにより、市場は拡大を続けています。

世界の人工呼吸器市場は、大気汚染、喫煙、高齢化などの要因によるCOPD、喘息、ARDS、肺炎などの呼吸器疾患の増加によって牽引されています。COVID-19パンデミックは、病院、在宅医療、救急医療における人工呼吸器の必要性を強調し、市場の成長を加速させ、深刻な呼吸困難に対処しています。

例えば、NCD Allianceによると、慢性呼吸器疾患（CRDs）は肺に関連する疾患で、世界中で重大な罹患率と死亡率を引き起こしています。一般的なCRDには、COPD、喘息、肺がん、職業性肺疾患が含まれます。これらの疾患は、全世界で少なくとも5,500億人の成人が罹患しており、全死亡の7％を占めています。肺がんはさらに年間14億人の死亡の原因となっています。

肺炎のような急性感染症や喘息のような慢性疾患を含め、5歳未満の子どもは特に肺疾患の影響を受けています。喘息は最も一般的な慢性疾患であり、全世界の子どもの14％が罹患しています。さらに、米国疾病予防管理センターの報告によると、2024年10月1日から11月30日の間に、RSVによる入院患者数は17,000人から34,000人でした。

人工呼吸器市場は、厳しい規制の枠組み、広範な試験、臨床試験、認証プロセスによる課題に直面しており、これらは製品化までの時間を遅らせ、コストを増加させる可能性があります。メーカーは進化する基準に適応しなければならないため、技術革新の妨げとなり、製品上市が複雑となり、市場の成長を抑制する可能性があります。

当レポートでは、世界の人工呼吸器市場について調査し、市場の概要とともに、タイプ別、インターフェース別、エンドユーザー別、地域別動向、競合情勢、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 調査手法と範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
    • 抑制要因
    • 影響分析

第5章 戦略的洞察と業界の展望

  • 市場のリーダーと先駆者
  • CXOの視点
  • 最新の開発とブレークスルー
  • ケーススタディ/進行中の調査
  • 規制と償還の情勢
  • ポーターのファイブフォース分析
  • パイプライン分析
  • サプライチェーン分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格動向
  • キーオピニオンリーダー

第6章 タイプ別

  • 成人用人工呼吸器
  • モビリティ
  • 集中治療用人工呼吸器
  • ポータブル/可搬型人工呼吸器

第7章 インターフェース別

  • 侵襲的人工呼吸器
  • 非侵襲的人工呼吸器

第8章 エンドユーザー別

  • 病院・クリニック
  • 在宅ケア
  • 外来診療センター
  • 救急医療サービス（EMS）

第9章 地域別

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他
  • ラテンアメリカ
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他
  • 中東・アフリカ

第10章 競合情勢

第11章 企業プロファイル

  • Philips Healthcare
  • ResMed Inc
  • Medtronic plc
  • GE Healthcare
  • Dragerwerk AG &Co. KGaA
  • Hamilton Medical AG
  • Fisher &Paykel Healthcare Corporation Limited
  • Getinge AB
  • Vyaire Medical
  • AgVa Healthcare
  • SCHILLER Healthcare India Private Limited
  • Biovo Technologies Ltd.
  • Breas Medical AB
  • Enexor BioEnergy LLC

第12章 付録

目次
Product Code: MD9321

The global ventilators market reached US$ 6.06 billion in 2024 and is expected to reach US$ 18.35 billion by 2033, growing at a CAGR of 11.7% during the forecast period 2025-2033.

The global ventilators market is vital in respiratory care, providing life-saving support to patients with conditions like COPD, pneumonia and ARDS. It is segmented based on mobility, type, interface, and end-users, with intensive care and portable ventilators being key categories. Leading companies like Philips Healthcare, Medtronic and GE Healthcare dominate the market while emerging players like SCHILLER Healthcare and Ventis Medical Inc. introduce innovative solutions. The market continues to expand due to technological advancements, rising respiratory diseases, and the growing demand for non-invasive ventilation.

Market Dynamics: Drivers & Restraints

Rising Prevalence of Respiratory Diseases

The global ventilators market is driven by the rise in respiratory diseases like COPD, asthma, ARDS, and pneumonia, driven by factors like air pollution, smoking, and aging populations. The COVID-19 pandemic underscored the need for ventilators in hospitals, home care, and emergency care, accelerating market growth and addressing severe respiratory distress.

For instance, according to the NCD Alliance, Chronic respiratory diseases (CRDs) are lung-related diseases that cause significant morbidity and mortality worldwide. Common CRDs include COPD, asthma, lung cancer, and occupational lung diseases. These diseases affect at least 550 Billion adults globally and account for 7% of all deaths. Lung cancer contributes to another 1.4 Billion deaths annually.

Children under five years of age are particularly affected by lung diseases, including acute infectious diseases like pneumonia and chronic conditions like asthma. Asthma is the most common chronic condition, affecting 14% of children globally. Moreover, according to the Centers for Disease Control and Prevention reports between October 1 and November 30, 2024, there were between 17,000 and 34,000 hospitalizations due to RSV.

Stringent Regulatory Environment and Compliance Requirements

The ventilators market faces challenges due to strict regulatory frameworks, extensive testing, clinical trials, and certification processes, which can delay time-to-market and increase costs. Manufacturers must adapt to evolving standards, which can hinder innovation and complicate product launches, restraining market growth.

Segment Analysis

The global ventilators market is segmented based on type, mobility, interface, end user and region.

Type:

The adult ventilators in the type segment are expected to dominate the ventilators market with the highest market share

Adult ventilators are mechanical devices used to provide respiratory support to adults with breathing difficulties or respiratory failure. They deliver controlled oxygen and remove carbon dioxide, ensuring adequate gas exchange in the lungs. Commonly used in ICUs, emergency rooms, and home care for conditions like COPD, ARDS, and post-surgical recovery.

The adult ventilator market is fueled by rising respiratory diseases like COPD, ARDS, and pneumonia, as well as the geriatric population's increased susceptibility to respiratory illnesses. Moreover, product launches, technological advancements like AI integration and the development of portable and home-use ventilators are driving market growth. The increasing number of ICU admissions, awareness of critical care infrastructure, and government initiatives to strengthen healthcare systems, particularly after the COVID-19 pandemic, are also driving market expansion.

For instance, in February 2024, Getinge launched its Sewo-c mechanical ventilator in India, designed to cater to the diverse respiratory needs of both pediatric and adult patients. The launch is a significant step towards making advanced healthcare solutions accessible and affordable for hospitals across India.

Geographical Analysis

North America is expected to hold a significant position in the ventilators market with the highest market share

North America is experiencing significant growth in the ventilators market due to its advanced healthcare infrastructure, significant medical technology investment, and high demand for respiratory care solutions. Government initiatives and reimbursement policies support advanced ventilator systems, especially in critical care settings. The COVID-19 pandemic has accelerated investments in intensive care infrastructure, emphasizing the need for reliable ventilator support.

The presence of major players in the region is focussing on product launches with advancements, driving the market growth in the region. For instance, in October 2024, Nihon Kohden America, a global medical technology leader, introduced the NKV-440 Ventilator System, previously available through OrangeMed, to a wider range of healthcare providers.

Competitive Landscape

The major global players in the ventilators market include Philips Healthcare, ResMed Inc., Medtronic plc, GE Healthcare, Dragerwerk AG & Co. KGaA, Hamilton Medical AG, Fisher & Paykel Healthcare Corporation Limited, Getinge AB, Vyaire Medical and AgVa Healthcare among others.

Key Developments

  • In November 2024, CorVent Medical received FDA 510(k) clearance for its RESPOND ventilator, a cost-effective, safe, and smart ventilation system designed to improve healthcare access for healthcare systems, providers, and patients.
  • In July 2024, Air Liquide Medical Systems has introduced the Monnal TEO, a French ventilator designed for intensive care and critical care services. The ventilator, developed in collaboration with the Angers University Hospital's intensive care unit, is a pioneering addition to the company's mechanical ventilation history. The ventilator is designed to provide superior comfort and efficiency in healthcare settings.

Why Purchase the Report?

  • Technological Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Type & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

The global ventilators market report delivers a detailed analysis with 61 key tables, more than 59 visually impactful figures, and 220 pages of expert insights, providing a complete view of the market landscape.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Mobility
  • 3.3. Snippet by Interface
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Prevalence of Respiratory Diseases
      • 4.1.1.2. Rise in the Technological Advancements
    • 4.1.2. Restraints
      • 4.1.2.1. Stringent Regulatory Environment and Compliance Requirements
      • 4.1.2.2. Limited Healthcare Infrastructure in Emerging Regions
    • 4.1.3. Opportunity
      • 4.1.3.1. Expansion in Homecare Ventilation
    • 4.1.4. Impact Analysis

5. Strategic Insights and Industry Outlook

  • 5.1. Market Leaders and Pioneers
    • 5.1.1. Emerging Pioneers and Prominent Players
    • 5.1.2. Established leaders with largest selling Brand
    • 5.1.3. Market leaders with established Product
  • 5.2. CXO Perspectives
  • 5.3. Latest Developments and Breakthroughs
  • 5.4. Case Studies/Ongoing Research
  • 5.5. Regulatory and Reimbursement Landscape
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa
  • 5.6. Porter's Five Force Analysis
  • 5.7. Pipeline Analysis
  • 5.8. Supply Chain Analysis
  • 5.9. Patent Analysis
  • 5.10. SWOT Analysis
  • 5.11. Unmet Needs and Gaps
  • 5.12. Recommended Strategies for Market Entry and Expansion
  • 5.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 5.14. Pricing Analysis and Price Dynamics
  • 5.15. Key Opinion Leaders

6. By Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 6.1.2. Market Attractiveness Index, By Type
  • 6.2. Adult Ventilators*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 6.2.3. Pediatric Ventilators
    • 6.2.4. Neonatal/Infant Ventilators
  • 6.3. By Mobility
  • 6.4. Introduction
    • 6.4.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility
    • 6.4.2. Market Attractiveness Index, By Mobility
  • 6.5. Intensive Care Ventilators*
    • 6.5.1. Introduction
    • 6.5.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.6. Portable/Transportable Ventilators

7. By Interface

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Interface
    • 7.1.2. Market Attractiveness Index, By Interface
  • 7.2. Invasive Ventilation*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Non-Invasive Ventilation

8. By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.1.2. Market Attractiveness Index, By End User
  • 8.2. Hospitals & Clinics*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Home Care Settings
  • 8.4. Ambulatory Care Centers
  • 8.5. Emergency Medical Services (EMS)

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Interface
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Interface
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. Latin America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Interface
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Mexico
      • 9.4.7.2. Brazil
      • 9.4.7.3. Argentina
      • 9.4.7.4. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Interface
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Interface
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

Key Market Players

  • 11.1. Philips Healthcare*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue's
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals etc.
    • 11.1.5. SWOT Analysis
  • 11.2. ResMed Inc
  • 11.3. Medtronic plc
  • 11.4. GE Healthcare
  • 11.5. Dragerwerk AG & Co. KGaA
  • 11.6. Hamilton Medical AG
  • 11.7. Fisher & Paykel Healthcare Corporation Limited
  • 11.8. Getinge AB
  • 11.9. Vyaire Medical
  • 11.10. AgVa Healthcare
  • Similar data will be provided for each market player.

Emerging Market Players

  • 11.11. SCHILLER Healthcare India Private Limited*
    • 11.11.1. Pipeline Products Description
    • 11.11.2. Product Key Performance Indicators (KPIs)
    • 11.11.3. Key Activities
    • 11.11.4. Market Entry Timelines
    • 11.11.5. Product Penetration Rate
    • 11.11.6. Sales Estimation and Projections
  • 11.12. Biovo Technologies Ltd.
  • 11.13. Breas Medical AB
  • 11.14. Enexor BioEnergy LLC
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1 About Us and Services
  • 12.2 Contact Us